Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow-to-Debt Ratio
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow-to-Debt Ratio of -0.11x as of June 2025, meaning its operating cash flow of ₩-15.17 Billion could theoretically repay 0% of its total liabilities (₩142.34 Billion) in one year. Explore Sam Chun Dang Pharm. Co. Ltd (000250) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Sam Chun Dang Pharm. Co. Ltd across 13 annual periods. Also explore 000250 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for Sam Chun Dang Pharm. Co. Ltd. For market capitalisation and broader financial context, see Sam Chun Dang Pharm. Co. Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩21.77 Billion | ₩253.67 Billion | ▼ -59.9% |
| 2023 | 0.21x | ₩23.43 Billion | ₩109.56 Billion | ▲ +220.5% |
| 2022 | 0.07x | ₩13.28 Billion | ₩199.05 Billion | ▲ +248.8% |
| 2021 | -0.04x | ₩-7.71 Billion | ₩171.90 Billion | ▼ -280.0% |
| 2020 | 0.02x | ₩3.25 Billion | ₩130.45 Billion | ▼ -89.2% |
| 2019 | 0.23x | ₩30.60 Billion | ₩132.28 Billion | ▲ +4.1% |
| 2018 | 0.22x | ₩25.03 Billion | ₩112.64 Billion | ▼ -24.3% |
| 2017 | 0.29x | ₩26.09 Billion | ₩88.80 Billion | ▲ +32.2% |
| 2016 | 0.22x | ₩17.76 Billion | ₩79.95 Billion | ▼ -10.4% |
| 2015 | 0.25x | ₩17.34 Billion | ₩69.94 Billion | ▼ -58.4% |
| 2014 | 0.60x | ₩19.55 Billion | ₩32.81 Billion | ▲ +35.1% |
| 2013 | 0.44x | ₩15.94 Billion | ₩36.15 Billion | ▲ +875.6% |
| 2012 | 0.05x | ₩1.60 Billion | ₩35.44 Billion | — |